Fulgent Genetics, Inc. (FLGT): Operating Income
-$91.10M
Year ended 2025-12-31
-$122.28M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$91.10M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | -$73.92M | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | -$195.53M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $178.53M | -73.6% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $675.95M | +133.0% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $290.16M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$428.0K | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$5.07M | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | -$3.48M | n/m | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $918.0K | n/m | 2018-03-20, From 2016-01-01 |
| 2015-12-31 | -$5.01M | n/m | 2017-03-17, From 2015-01-01 |
| 2014-12-31 | -$990.0K | n/a | 2017-03-17, From 2014-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$91.10M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $16.02M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | -$42.81M | n/m |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$30.78M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $57.78M | +257.9% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$562.16M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $45.11M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$437.25M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$27.87M | n/m |
Compare FLGT, BLLN, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗